Scientifically Grasp Multidisciplinary Sequential Treatment of Colorectal Liver Metastases_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

叶颖江 , 郭鹏

Corresponding author：

Keywords：

结直肠癌; 肝转移癌; 多学科综合治疗

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 叶颖江,郭鹏. Scientifically Grasp Multidisciplinary Sequential Treatment of Colorectal Liver Metastases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2011, 18(5): 469-472. doi: Copy

1.	Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin, 2010, 60(5): 277300.
2.	Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? [J]. J Clin Oncol, 2005, 23(33): 84908499.
3.	Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection [J]. Surgery, 1988, 103(3): 278288.
4.	Nordlinger B, Van Cutsem E, Rougier P, et al. European Colorectal Metastases Treatment Group. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group [J]. Eur J Cancer, 2007, 43(14): 20372045.
5.	Nordlinger B, Van Cutsem E, Gruenberger T, et al. European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel [J]. Ann Oncol, 2009, 20(6): 985992.
6.	Figueras J, Torras J, Valls C, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a singlecenter experience with 501 patients [J]. Dis Colon Rectum, 2007, 50(4): 478488.
7.	Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in longterm survival following liver resection for hepatic colorectal metastases [J]. Ann Surg, 2002, 235(6): 759766.
8.	Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial [J]. Lancet, 2008, 371(9617): 10071016.
9.	Elias D, Youssef O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy [J]. J Surg Oncol, 2004, 86(1): 49.
10.	Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? [J]. J Clin Oncol, 2006, 24(24): 39393945.
11.	Mentha G, Majno P, Terraz S, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour [J]. Eur J Surg Oncol, 2007, 33 Suppl 2: S76S83.
12.	Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1 568 patients. Association Franaise de Chirurgie [J]. Cancer, 1996, 77(7): 12541262.
13.	Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [J]. Ann Surg, 2000, 231(5): 743751.
14.	Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases [J]. Surgery, 2004, 136(3): 650659.
15.	Peeters CF, de Waal RM, Wobbes T, et al. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation [J]. Int J Cancer, 2006, 119(6): 12491253.
16.	Verhoef C, van der Pool AE, Nuyttens JJ, et al. The “liverfirst approach” for patients with locally advanced rectal cancer and synchronous liver metastases [J]. Dis Colon Rectum, 2009, 52(1): 2330.
17.	Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial [J]. J Clin Oncol, 2006, 24(31): 49764982.
18.	Khne CH, van Cutsem E, Wils J, et al. Phase Ⅲ study of weekly highdose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986 [J]. J Clin Oncol, 2005, 23(22): 48564865.
19.	Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J]. J Clin Oncol, 2004, 22(1): 2330.
20.	Falcone A, Ricci S, Brunetti I, et al. Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as firstline treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest [J]. J Clin Oncol, 2007, 25(13): 16701676.
21.	Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization [J]. Arch Surg, 2002, 137(6): 675680.
22.	Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation [J]. N Engl J Med, 2007, 356(15): 15451559.
23.	Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization [J]. Hepatology, 2001, 34(2): 267272.
24.	Kemeny NE, Melendez FD, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma [J]. J Clin Oncol, 2009, 27(21): 34653471.
25.	Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study [J]. J Clin Oncol, 2004, 22(2): 229237.
26.	Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 [J]. J Clin Oncol, 2007, 25(12): 15391544.
27.	Sobrero AF, Maurel J, Fehrenbacher L, et al. EPIC: phase Ⅲ trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer [J]. J Clin Oncol， 2008 ， 26(14): 23112319.
28.	Gallagher DJ, Capanu M, Raggio G, et al. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis [J]. Ann Oncol, 2007, 18(12): 19951999.
29.	Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer [J]. J Clin Oncol, 2005, 23(22): 48814887.

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin, 2010, 60(5): 277300.
2. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? [J]. J Clin Oncol, 2005, 23(33): 84908499.
3. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection [J]. Surgery, 1988, 103(3): 278288.
4. Nordlinger B, Van Cutsem E, Rougier P, et al. European Colorectal Metastases Treatment Group. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group [J]. Eur J Cancer, 2007, 43(14): 20372045.
5. Nordlinger B, Van Cutsem E, Gruenberger T, et al. European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel [J]. Ann Oncol, 2009, 20(6): 985992.
6. Figueras J, Torras J, Valls C, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a singlecenter experience with 501 patients [J]. Dis Colon Rectum, 2007, 50(4): 478488.
7. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in longterm survival following liver resection for hepatic colorectal metastases [J]. Ann Surg, 2002, 235(6): 759766.
8. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial [J]. Lancet, 2008, 371(9617): 10071016.
9. Elias D, Youssef O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy [J]. J Surg Oncol, 2004, 86(1): 49.
10. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? [J]. J Clin Oncol, 2006, 24(24): 39393945.
11. Mentha G, Majno P, Terraz S, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour [J]. Eur J Surg Oncol, 2007, 33 Suppl 2: S76S83.
12. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1 568 patients. Association Franaise de Chirurgie [J]. Cancer, 1996, 77(7): 12541262.
13. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [J]. Ann Surg, 2000, 231(5): 743751.
14. Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases [J]. Surgery, 2004, 136(3): 650659.
15. Peeters CF, de Waal RM, Wobbes T, et al. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation [J]. Int J Cancer, 2006, 119(6): 12491253.
16. Verhoef C, van der Pool AE, Nuyttens JJ, et al. The “liverfirst approach” for patients with locally advanced rectal cancer and synchronous liver metastases [J]. Dis Colon Rectum, 2009, 52(1): 2330.
17. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial [J]. J Clin Oncol, 2006, 24(31): 49764982.
18. Khne CH, van Cutsem E, Wils J, et al. Phase Ⅲ study of weekly highdose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986 [J]. J Clin Oncol, 2005, 23(22): 48564865.
19. Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J]. J Clin Oncol, 2004, 22(1): 2330.
20. Falcone A, Ricci S, Brunetti I, et al. Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as firstline treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest [J]. J Clin Oncol, 2007, 25(13): 16701676.
21. Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization [J]. Arch Surg, 2002, 137(6): 675680.
22. Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation [J]. N Engl J Med, 2007, 356(15): 15451559.
23. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization [J]. Hepatology, 2001, 34(2): 267272.
24. Kemeny NE, Melendez FD, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma [J]. J Clin Oncol, 2009, 27(21): 34653471.
25. Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study [J]. J Clin Oncol, 2004, 22(2): 229237.
26. Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 [J]. J Clin Oncol, 2007, 25(12): 15391544.
27. Sobrero AF, Maurel J, Fehrenbacher L, et al. EPIC: phase Ⅲ trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer [J]. J Clin Oncol， 2008 ， 26(14): 23112319.
28. Gallagher DJ, Capanu M, Raggio G, et al. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis [J]. Ann Oncol, 2007, 18(12): 19951999.
29. Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer [J]. J Clin Oncol, 2005, 23(22): 48814887.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Scientifically Grasp Multidisciplinary Sequential Treatment of Colorectal Liver Metastases

Abstract Full text Figures/Tables Video References Cited by

Format

Content